Belén Garijo is a Spanish business executive. Since May 2021, she has been the CEO and chair of the executive board of Merck Group. From Wikipedia
The deal aims to bolster Merck's rare tumor treatments, accelerate growth, and expand its U.S. presence, pending regulatory and shareholder approvals.
